Literature DB >> 10974650

Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer.

R Hochscheid1, G Jaques, B Wegmann.   

Abstract

IGF-I and IGF-II are potent mitogens, postulated to exert autocrine/paracrine effects on growth regulation in human lung cancer. Their proliferative effects are modulated by IGF-binding proteins (IGFBPs), which are found in conditioned medium (CM) of lung cancer cell lines. The biological role of the IGFBPs, which are ontogenetically and hormonally regulated, is not fully understood. Both inhibitory and stimulatory effects on cell growth have been demonstrated. Exogenous IGFBP-3 has been consistently shown to block IGF action, inhibiting cell growth in vitro. In order to evaluate the action of endogenously produced IGFBP-3 on cell growth in lung cancer, we stably transfected the non-small cell lung cancer cell line NCI-H23 with human IGFBP-3 cDNA (resulting in NCI-H23 pOPI3/BP-3) or with the vector pOPI3CAT as control (resulting in NCI-H23 pOPI3CAT). RT-PCR confirmed expression of IGFBP-3-specific mRNA in NCI-H23 pOPI3/BP-3, but not in N! CI-H23 or NCI-H23 pOPI3CAT. Western ligand blot and Western immunoblot analysis of CMs yielded strong signals of the characteristic 40-44 kDa human IGFBP-3 protein in NCI-H23 pOPI3/BP-3. An IGFBP-3 ELISA demonstrated a 20-fold increase in IGFBP-3 protein expression in NCI-H23 pOPI3/BP-3 as compared with NCI-H23. The growth of NCI-H23 pOPI3/BP-3 in serum-containing medium was significantly slower (1.7-fold) than that of NCI-H23 or the vector-transfected control NCI-H23 pOPI3CAT. While the proliferation rate of parental and vector-transfected cells could be stimulated by IGF-I, IGF-II, IGF-I analog Long R(3) IGF-I or insulin, that of NCI-H23 pOPI3/BP-3 could not. Xenotransplantation in nude mice resulted in marked tumor growth after the injection of NCI-H23 or NCI-H23 pOPI3CAT, but absent or minimal growth for the IGFBP-3-transfected cell line. These data suggest that IGFBP-3 is a potent inhibitor of cell growth in human lung cancer c! ell lines and may impair tumorigenicity in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10974650     DOI: 10.1677/joe.0.1660553

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  9 in total

1.  IGFBP-3, a marker of cellular senescence, is overexpressed in human papillomavirus-immortalized cervical cells and enhances IGF-1-induced mitogenesis.

Authors:  Astrid C Baege; Gary L Disbrow; Richard Schlegel
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Activation of various downstream signaling molecules by IGFBP-3.

Authors:  Hanief Mohammad Shahjee; Nisan Bhattacharyya
Journal:  J Cancer Ther       Date:  2014-08-01

Review 3.  Lung cancer. 9: Molecular biology of lung cancer: clinical implications.

Authors:  K M Fong; Y Sekido; A F Gazdar; J D Minna
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

Review 4.  The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes.

Authors:  Swapnil N Rajpathak; Marc J Gunter; Judith Wylie-Rosett; Gloria Y F Ho; Robert C Kaplan; Radhika Muzumdar; Thomas E Rohan; Howard D Strickler
Journal:  Diabetes Metab Res Rev       Date:  2009-01       Impact factor: 4.876

5.  IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms.

Authors:  Munenori Takaoka; Seok-Hyun Kim; Takaomi Okawa; Carmen Z Michaylira; Douglas B Stairs; Cameron N Johnstone; Claudia D Andl; Ben Rhoades; James J Lee; Andres J P Klein-Szanto; Wafik S El-Deiry; Hiroshi Nakagawa
Journal:  Cancer Biol Ther       Date:  2007-04       Impact factor: 4.742

6.  Associations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 with HIV disease progression in women.

Authors:  Howard D Strickler; Melissa Fazzari; Andrea Kovacs; Carmen Isasi; Laura A Napolitano; Howard Minkoff; Stephen Gange; Mary Young; Gerald B Sharp; Robert C Kaplan; Mardge Cohen; Marc J Gunter; Tiffany G Harris; Herbert Yu; Ellie Schoenbaum; Alan L Landay; Kathryn Anastos
Journal:  J Infect Dis       Date:  2008-01-15       Impact factor: 5.226

7.  A Hospital Based Study to Establish the Correlation between Recurrent Wheeze and Vitamin D Deficiency Among Children of Age Group Less than 3 Years in Indian Scenario.

Authors:  Santosh Prasad; Rishabh Kumar Rana; Ronak Sheth; Anupama V Mauskar
Journal:  J Clin Diagn Res       Date:  2016-02-01

8.  IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumors.

Authors:  Ivonne Regel; Melanie Eichenmüller; Saskia Joppien; Johanna Liebl; Beate Häberle; Josef Müller-Höcker; Angelika Vollmar; Dietrich von Schweinitz; Roland Kappler
Journal:  Mol Cancer       Date:  2012-03-08       Impact factor: 27.401

9.  Gene expression and prognosis of insulin‑like growth factor‑binding protein family members in non‑small cell lung cancer.

Authors:  Jiao Wang; Zhi-Guo Hu; Dan Li; Ji-Xion Xu; Zhen-Guo Zeng
Journal:  Oncol Rep       Date:  2019-09-16       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.